Senescence and Arrhythmogenesis

  • Mahek Mirza
  • Win-Kuang Shen
  • Arshad Jahangir


Cardiac arrhythmias are a major cause of morbidity and mortality, particularly in the elderly. With the rapidly changing population demographics, and increasing prevalence of cardiovascular disease, healthcare resource utilization for arrhythmia care is projected to rise exponentially. Aging is associated with electrophysiological alterations due to cardiac structural and functional remodeling, which combined with a blunted response to neurohumoral activation and hemodynamic responsiveness, results in increased propensity to brady and tachy-arrhythmias. These not only affect the quality of life but also contribute to the deterioration in myocardial function leading to heart failure, stroke and death.

Despite progress in the management of cardiovascular disease, arrhythmias in the elderly, continue to be a significant predicament. This is mainly due to limited understanding of the mechanisms and therapeutics directed against the underlying substrate that increases susceptibility of the heart to arrhythmogenesis and paucity of outcome studies in the older-elderly that limits specific practice guidelines in octo- and nona-genarians. Hence, further investigation is warranted to fully define the efficacy of anti-arrhythmic therapeutic modalities in the elderly that have proven to be effective in younger patients. This chapter summarizes the epidemiology, aging-associated cardiac structural and functional changes, basis for arrhythmogenesis, evaluation and management of elderly patients with ventricular tachyarrhythmias that increase predisposition to sudden death.


Elderly Arrhythmia Sudden cardiac death Implantable cardioverter defibrillator Anti-arrhythmic drugs Ablation Aging 



Drs. Jahangir and Mirza’s research effort was in part supported by the National Heart, Lung, and Blood Institute grants RO1 HL101240-02 and R01 HL089542-04.


  1. 1.
    Roger VL, Go AS, Lloyd-Jones DM, Benjamin EJ, Berry JD, Borden WB, et al. Heart disease and stroke statistics – 2012 update: a report from the American Heart Association. Circulation. 2012;125:e2–220.PubMedCrossRefGoogle Scholar
  2. 2.
    Lakatta EG, Sollott SJ. Perspectives on mammalian cardiovascular aging: humans to molecules. Comp Biochem Physiol A Mol Integr Physiol. 2002;132:699–721.PubMedCrossRefGoogle Scholar
  3. 3.
    Chugh SS JJ, Gunson K, Stecker EC, John BT, Thompson B, Ilias N, et al. Current burden of sudden cardiac death: multiple source surveillance versus retrospective death certificate-based review in a large U.S. community. J Am Coll Cardiol. 2004;44:1268–75.PubMedCrossRefGoogle Scholar
  4. 4.
    Piccini JP, Hammill BG, Sinner MF, Jensen PN, Hernandez AF, Heckbert SR, et al. Incidence and prevalence of atrial fibrillation and associated mortality among medicare beneficiaries, 1993–2007. Circ Cardiovasc Qual Outcomes. 2012;5:85–93.PubMedCrossRefGoogle Scholar
  5. 5.
    Zipes DP CA, Borggrefe M, Buxton AE, Chaitman B, Fromer M, Gregoratos G, et al. ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death). J Am Coll Cardiol. 2006;48:e247–346.PubMedCrossRefGoogle Scholar
  6. 6.
    Jacobs AK, Adams CD, Anderson JL, Antman EM, Hunt SA, Nishimura R, et al. ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation-executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to revise the 2001 Guidelines for the Management of Patients with Atrial Fibrillation). Circulation. 2006;114:700–52.CrossRefGoogle Scholar
  7. 7.
    Kistler PM, Sanders P, Fynn SP, Stevenson IH, Spence SJ, Vohra JK, et al. Electrophysiologic and electroanatomic changes in the human atrium associated with age. J Am Coll Cardiol. 2004;44:109–16.PubMedCrossRefGoogle Scholar
  8. 8.
    Preston CC, Oberlin AS, Holmuhamedov EL, Gupta A, Sagar S, Syed RH, et al. Aging-induced alterations in gene transcripts and functional activity of mitochondrial oxidative phosphorylation complexes in the heart. Mech Ageing Dev. 2008;129:304–12.PubMedCrossRefGoogle Scholar
  9. 9.
    Roberts-Thomson KC, Kistler PM, Sanders P, Morton JB, Haqqani HM, Stevenson I, et al. Fractionated atrial electrograms during sinus rhythm: relationship to age, voltage, and conduction velocity. Heart Rhythm. 2009;6:587–91.PubMedCrossRefGoogle Scholar
  10. 10.
    Dun W, Boyden PA. Aged atria: electrical remodeling conducive to atrial fibrillation. J Interv Card Electrophysiol. 2009;25:9–18.PubMedCrossRefGoogle Scholar
  11. 11.
    Tellez JO, McZewski M, Yanni J, Sutyagin P, Mackiewicz U, Atkinson A, et al. Ageing-dependent remodelling of ion channel and Ca2+ clock genes underlying sino-atrial node pacemaking. Exp Physiol. 2011;96:1163–78.PubMedGoogle Scholar
  12. 12.
    Lie JT, Hammond PI. Pathology of the senescent heart: anatomic observations on 237 autopsy studies of patients 90 to 105 years old. Mayo Clin Proc. 1988;63:552–64.PubMedCrossRefGoogle Scholar
  13. 13.
    Cheitlin MD. Cardiovascular physiology-changes with aging. Am J Geriatr Cardiol. 2003;12:9–13.PubMedCrossRefGoogle Scholar
  14. 14.
    Huang C, Ding W, Li L, Zhao D. Differences in the aging-associated trends of the monophasic action potential duration and effective refractory period of the right and left atria of the rat. Circ J. 2006;70:352–7.PubMedCrossRefGoogle Scholar
  15. 15.
    Liu XK, Jahangir A, Terzic A, Gersh BJ, Hammill SC, Shen WK. Age- and sex-related atrial electrophysiologic and structural changes. Am J Cardiol. 2004;94:373–5.PubMedCrossRefGoogle Scholar
  16. 16.
    Aronow WS. Heart disease and aging. Med Clin North Am. 2006;90:849–62.PubMedCrossRefGoogle Scholar
  17. 17.
    Liu XK, JA, Shen WK. Cardiac arrhythmias. In: Halter JB, Ouslander JG, Tinetti ME, Studenski S, High KP, Asthana S, editors. Hazzard’s Geriatric Medicine and Gerontology, Sixth Edition. New York: McGraw-Hill; 2009. p. 951–65.Google Scholar
  18. 18.
    Jahangir A, Lee V, Friedman PA, Trusty JM, Hodge DO, Kopecky SL, et al. Long-term progression and outcomes with aging in patients with lone atrial fibrillation: a 30-year follow-up study. Circulation. 2007;115:3050–6.PubMedCrossRefGoogle Scholar
  19. 19.
    Go ASHE, Phillips KA, Chang Y, Henault LE, Selby JV, Singer DE. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. JAMA. 2001;285:2370–5.PubMedCrossRefGoogle Scholar
  20. 20.
    Jahangir A, Shen WK. Pacing in elderly patients. Am Heart J. 2003;146:750–3.PubMedCrossRefGoogle Scholar
  21. 21.
    Jahangir A, Sagar S, Terzic A. Aging and cardioprotection. J Appl Physiol. 2007;103:2120–8.PubMedCrossRefGoogle Scholar
  22. 22.
    Adabag AS, Luepker RV, Roger VL, Gersh BJ. Sudden cardiac death: epidemiology and risk factors. Nat Rev Cardiol. 2010;7:216–25.PubMedCrossRefGoogle Scholar
  23. 23.
    Chugh SS, Jui J, Gunson K, Stecker EC, John BT, Thompson B, et al. Current burden of sudden cardiac death: multiple source surveillance versus retrospective death certificate-based review in a large U.S. community. J Am Coll Cardiol. 2004;44:1268–75.PubMedCrossRefGoogle Scholar
  24. 24.
    Myerburg RJ, Hendel RC. Expanding risk-profiling strategies for prediction and prevention of sudden cardiac death. J Am Coll Cardiol. 2010;56:215–7.PubMedCrossRefGoogle Scholar
  25. 25.
    Fishman GI, Chugh SS, Dimarco JP, Albert CM, Anderson ME, Bonow RO, et al. Sudden cardiac death prediction and prevention: report from a national heart, lung, and blood institute and heart rhythm society workshop. Circulation. 2010;122:2335–48.PubMedCrossRefGoogle Scholar
  26. 26.
    Gillum RF. Geographic variation in sudden coronary death. Am Heart J. 1990;119:380–9.PubMedCrossRefGoogle Scholar
  27. 27.
    Chugh SS. Early identification of risk factors for sudden cardiac death. Nat Rev Cardiol. 2010;7:318–26.PubMedCrossRefGoogle Scholar
  28. 28.
    Nichol G, Thomas E, Callaway CW, Hedges J, Powell JL, Aufderheide TP, et al. Regional variation in out-of-hospital cardiac arrest incidence and outcome. JAMA. 2008;300:1423–31.PubMedCrossRefGoogle Scholar
  29. 29.
    Zipes DP, Camm AJ, Borggrefe M, Buxton AE, Chaitman B, Fromer M, et al. ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death). J Am Coll Cardiol. 2006;48:e247–346.PubMedCrossRefGoogle Scholar
  30. 30.
    Myerburg RJ, Castellanos A. Emerging paradigms of the epidemiology and demographics of sudden cardiac arrest. Heart Rhythm. 2006;3:235–9.PubMedCrossRefGoogle Scholar
  31. 31.
    Myerburg RJ. Sudden cardiac death: exploring the limits of our knowledge. J Cardiovasc Electrophysiol. 2001;12:369–81.PubMedCrossRefGoogle Scholar
  32. 32.
    Theroux P, Fuster V. Acute coronary syndromes: unstable angina and non-q-wave myocardial infarction. Circulation. 1998;97:1195–206.PubMedCrossRefGoogle Scholar
  33. 33.
    Naghavi MFE, Hecht HS, Jamieson MJ, Kaul S, Berman D, Fayad Z, et al. From vulnerable plaque to vulnerable patient – Part III: executive summary of the Screening for Heart Attack Prevention and Education (SHAPE) Task Force Report. Am J Cardiol. 2006;17:2H–15.CrossRefGoogle Scholar
  34. 34.
    Farb A, Tang AL, Burke AP, Sessums L, Liang Y, Virmani R. Sudden coronary death: frequency of active coronary lesions, inactive coronary lesions, and myocardial infarction. Circulation. 1995;92:1701–9.PubMedCrossRefGoogle Scholar
  35. 35.
    Hulot JS, Jouven X, Empana JP, Frank R, Fontaine G. Natural history and risk stratification of arrhythmogenic right ventricular dysplasia/cardiomyopathy. Circulation. 2004;110:1879–84.PubMedCrossRefGoogle Scholar
  36. 36.
    Klein GJ, Krahn AD, Skanes AC, Yee R, Gula LJ. Primary prophylaxis of sudden death in hypertrophic cardiomyopathy, arrhythmogenic right ventricular cardiomyopathy, and dilated cardiomyopathy. J Cardiovasc Electrophysiol. 2005;16:S28–34.PubMedCrossRefGoogle Scholar
  37. 37.
    Gersh BJ, Maron BJ, Bonow RO, Dearani JA, Fifer MA, Link MS, et al. 2011 ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation. 2011;124:e783–831.PubMedCrossRefGoogle Scholar
  38. 38.
    Maron BJ. Contemporary insights and strategies for risk stratification and prevention of sudden death in hypertrophic cardiomyopathy. Circulation. 2010;121:445–56.PubMedCrossRefGoogle Scholar
  39. 39.
    Locati EH, Zareba W, Moss AJ, Schwartz PJ, Vincent GM, Lehmann MH, et al. Age- and sex-related differences in clinical manifestations in patients with congenital long-QT syndrome: findings from the International LQTS Registry. Circulation. 1998;97:2237–44.PubMedCrossRefGoogle Scholar
  40. 40.
    Bjerregaard PJA, Gussak I. Targeted therapy for short qt syndrome. Expert Opin Ther Targets. 2006;10:393–400.PubMedCrossRefGoogle Scholar
  41. 41.
    Friedlander Y, Siscovick DS, Weinmann S, Austin MA, Psaty BM, Lemaitre RN, et al. Family history as a risk factor for primary cardiac arrest. Circulation. 1998;97:155–60.PubMedCrossRefGoogle Scholar
  42. 42.
    Jouven X, Desnos M, Guerot C, Ducimetiere P. Predicting sudden death in the population. The Paris prospective study I. Circulation. 1999;99:1978–83.PubMedCrossRefGoogle Scholar
  43. 43.
    Cerrone M, Priori SG. Genetics of sudden death: focus on inherited channelopathies. Eur Heart J. 2011;32:2109–18.PubMedCrossRefGoogle Scholar
  44. 44.
    Faber BCG, Cleutjens KBJM, Niessen RLJ, Aarts PLJW, Boon W, Greenberg AS, et al. Identification of genes potentially involved in rupture of human atherosclerotic plaques. Circ Res. 2001;89:547–54.PubMedCrossRefGoogle Scholar
  45. 45.
    Topol EJ, McCarthy J, Gabriel S, Moliterno DJ, Rogers WJ, Newby LK, et al. Single nucleotide polymorphisms in multiple novel thrombospondin genes may be associated with familial premature myocardial infarction. Circulation. 2001;104:2641–4.PubMedCrossRefGoogle Scholar
  46. 46.
    Splawski I, Timothy KW, Tateyama M, Clancy CE, Malhotra A, Beggs AH, et al. Variant of SCN5A sodium channel implicated in risk of cardiac arrhythmia. Science. 2002;297:1333–6.PubMedCrossRefGoogle Scholar
  47. 47.
    Goldenberg I, Moss AJ, Bradley J, Polonsky S, Peterson DR, McNitt S, et al. Long-QT syndrome after age 40. Circulation. 2008;117:2192–201.PubMedCrossRefGoogle Scholar
  48. 48.
    Kannel WB, Cupples LA, D’Agostino RB. Sudden death risk in overt coronary heart disease: the Framingham Study. Am Heart J. 1987;113:799–804.PubMedCrossRefGoogle Scholar
  49. 49.
    Alpert MA. Obesity cardiomyopathy: pathophysiology and evolution of the clinical syndrome. Am J Med Sci. 2001;321:225–36.PubMedCrossRefGoogle Scholar
  50. 50.
    Bergner DW, Goldberger JJ. Diabetes mellitus and sudden cardiac death: what are the data? Cardiol J. 2010;17:117–29.PubMedGoogle Scholar
  51. 51.
    Spooner PM. Sudden cardiac death: influence of diabetes. Diabetes Obes Metab. 2008;10:523–32.PubMedCrossRefGoogle Scholar
  52. 52.
    Myerburg RJ, Kessler KM, Castellanos A. Sudden cardiac death: epidemiology, transient risk, and intervention assessment. Ann Intern Med. 1993;119:1187–97.PubMedCrossRefGoogle Scholar
  53. 53.
    Adamson P, Barr RC, Callans DJ, Chen PS, Lathrop DA, Makielski JC, et al. The perplexing complexity of cardiac arrhythmias: beyond electrical remodeling. Heart Rhythm. 2005;2:650–9.PubMedCrossRefGoogle Scholar
  54. 54.
    Juhaszova MRC, Zorov DB, Lakatta EG, Sollott SJ. Protection in the aged heart: preventing the heart-break of old age? Cardiovasc Res. 2005;66:233–44.PubMedCrossRefGoogle Scholar
  55. 55.
    Vlietstra REJA, Shen WK. Choice of pacemakers in patients aged 75 years and older: ventricular pacing mode vs. dual-chamber pacing mode. Am J Geriatr Cardiol. 2005;14:35–8.PubMedCrossRefGoogle Scholar
  56. 56.
    Epstein AE, DiMarco JP, Ellenbogen KA, Estes 3rd NA, Freedman RA, Gettes LS, et al. ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices) developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons. J Am Coll Cardiol. 2008;51:e1–62.PubMedCrossRefGoogle Scholar
  57. 57.
    Jose A. Effect of combined sympathetic and parasympathetic blockade on heart rate and cardiac function in man. Am J Cardiol. 1966;18:476–8.PubMedCrossRefGoogle Scholar
  58. 58.
    Lakatta EG. Cardiovascular regulatory mechanisms in advanced age. Physiol Rev. 1993;73:413–67.PubMedGoogle Scholar
  59. 59.
    Fleg JL, O’Connor F, Gerstenblith G, Becker LC, Clulow J, Schulman SP, et al. Impact of age on the cardiovascular response to dynamic upright exercise in healthy men and women. J Appl Physiol. 1995;78:890–900.PubMedGoogle Scholar
  60. 60.
    Koura THM, Takeuchi S, Ota K, Okada Y, Miyoshi S, Watanabe A, et al. Anisotropic conduction properties in canine atria analyzed by high-resolution optical mapping: preferential direction of conduction block changes from longitudinal to transverse with increasing age. Circulation. 2002;105:2092–8.PubMedCrossRefGoogle Scholar
  61. 61.
    de Bakker JM, van Rijen HM. Continuous and discontinuous propagation in heart muscle. J Cardiovasc Electrophysiol. 2006;17:567–73.PubMedCrossRefGoogle Scholar
  62. 62.
    Hao X, Zhang Y, Zhang X, Nirmalan M, Davies L, Konstantinou D, et al. TGF-beta1-mediated fibrosis and ion channel remodeling are key mechanisms in producing the sinus node dysfunction associated with SCN5A deficiency and aging. Circ Arrhythm Electrophysiol. 2011;4:397–406.PubMedCrossRefGoogle Scholar
  63. 63.
    Nerbonne JM, Kass RS. Physiology and molecular biology of ion channels contributing to ventricular repolarization. In: Gussak I, Antzelevitch C, Hammill SC, Shen WK, Bjerregaard P, editors. Cardiac repolarization: bridging basic and clinical science, Contemporary cardiology. Totowa, NJ: Humana Press; 2003. p. 25–62.CrossRefGoogle Scholar
  64. 64.
    Josephson IR, Guia A, Stern MD, Lakatta EG. Alterations in properties of L-type Ca channels in aging rat heart. J Mol Cell Cardiol. 2002;34:297–308.PubMedCrossRefGoogle Scholar
  65. 65.
    Jahangir A, Holmuhamedov EL, Cabrera Aguilera CC, Oberlin AS, Ashfaque N, Alekseev AE, et al. Molecular basis for the increased ­vulnerability of the aging heart to injury. Eur Heart J. 2006;27:S875.CrossRefGoogle Scholar
  66. 66.
    Lakatta EG, Maltsev VA, Vinogradova TM. A coupled SYSTEM of intracellular Ca2+ clocks and surface membrane voltage clocks controls the timekeeping mechanism of the heart’s pacemaker. Circ Res. 2010;106:659–73.PubMedCrossRefGoogle Scholar
  67. 67.
    Janczewski AMSH, Lakatta EG. Action potential prolongation in cardiac myocytes of old rats is an adaptation to sustain youthful intracellular Ca2+ regulation. J Mol Cell Cardiol. 2002;34:641–8.PubMedCrossRefGoogle Scholar
  68. 68.
    Walker KE, Lakatta EG, Houser SR. Alterations in properties of l-type ca channels in aging rat heart. Cardiovasc Res. 2002;27:1968–77.CrossRefGoogle Scholar
  69. 69.
    Walker KE, Lakatta EG, Houser SR. Age associated changes in membrane currents in rat ventricular myocytes. Cardiovasc Res. 1993;27:1968–77.PubMedCrossRefGoogle Scholar
  70. 70.
    Jahangir A, Terzic A. K(ATP) channel therapeutics at the bedside. J Mol Cell Cardiol. 2005;39:99–112.PubMedCrossRefGoogle Scholar
  71. 71.
    Toro LMJ, Nishimaru K, Tanaka Y, Song M, Stefani E. Aging, ion channel expression, and vascular function. Vascul Pharmacol. 2002;38:73–80.PubMedCrossRefGoogle Scholar
  72. 72.
    Zhou YY, Lakatta EG, Xiao RP. Age-associated alterations in calcium current and its modulation in cardiac myocytes. Drugs Aging. 1998;13:159–71.PubMedCrossRefGoogle Scholar
  73. 73.
    Xiao R-P, Zhu W, Zheng M, Cao C, Zhang Y, Lakatta EG, et al. Subtype-specific [alpha]1- and [beta]-adrenoceptor signaling in the heart. Trends Pharmacol Sci. 2006;27:330–7.PubMedCrossRefGoogle Scholar
  74. 74.
    Morita N, Lee JH, Bapat A, Fishbein MC, Mandel WJ, Chen PS, et al. Glycolytic inhibition causes spontaneous ventricular fibrillation in aged hearts. Am J Physiol Heart Circ Physiol. 2011;301:H180–91.PubMedCrossRefGoogle Scholar
  75. 75.
    Lompre AM, Lambert F, Lakatta EG, Schwartz K. Expression of sarcoplasmic reticulum Ca(2+). ATPase and calsequestrin genes in rat heart during ontogenic development and aging. Circ Res. 1991;69:1380–8.PubMedCrossRefGoogle Scholar
  76. 76.
    Taffet GE, Tate CA. CaATPase content is lower in cardiac sarcoplasmic reticulum isolated from old rats. Am J Physiol. 1993;264:H1609–14.PubMedGoogle Scholar
  77. 77.
    Koban MU, Moorman AF, Holtz J, Yacoub MH, Boheler KR. Expressional analysis of the cardiac Na-Ca exchanger in rat development and senescence. Cardiovasc Res. 1998;37:405–23.PubMedCrossRefGoogle Scholar
  78. 78.
    Xu A, Narayanan N. Effects of aging on sarcoplasmic reticulum Ca2+-cycling proteins and their phosphorylation in rat myocardium. Am J Physiol. 1998;275:H2087–94.PubMedGoogle Scholar
  79. 79.
    Jahangir A, Ozcan C, Holmuhamedov EL, Terzic A. Increased calcium vulnerability of senescent cardiac mitochondria: protective role for a mitochondrial potassium channel opener. Mech Ageing Dev. 2001;122:1073–86.PubMedCrossRefGoogle Scholar
  80. 80.
    Fleg JL, Kennedy HL. Cardiac arrhythmias in a healthy elderly population: detection by 24-hour ambulatory electrocardiography. Chest. 1982;81:302–7.PubMedCrossRefGoogle Scholar
  81. 81.
    Kennedy HL, Whitlock JA, Sprague MK, Kennedy LJ, Buckingham TA, Goldberg RJ. Long-term follow-up of asymptomatic healthy subjects with frequent and complex ventricular ectopy. N Engl J Med. 1985;312:193–7.PubMedCrossRefGoogle Scholar
  82. 82.
    Hinkle Jr LE, Carver ST, Stevens M. The frequency of asymptomatic disturbances of cardiac rhythm and conduction in middle-aged men. Am J Cardiol. 1969;24:629–50.PubMedCrossRefGoogle Scholar
  83. 83.
    Jouven X, Zureik M, Desnos M, Courbon D, Ducimetiere P. Long-term outcome in asymptomatic men with exercise-induced premature ventricular depolarizations. N Engl J Med. 2000;343:826–33.PubMedCrossRefGoogle Scholar
  84. 84.
    Frolkis JP, Pothier CE, Blackstone EH, Lauer MS. Frequent ventricular ectopy after exercise as a predictor of death. N Engl J Med. 2003;348:781–90.PubMedCrossRefGoogle Scholar
  85. 85.
    Messerli FH, Ventura HO, Elizardi DJ, Dunn FG, Frohlich ED. Hypertension and sudden death: increased ventricular ectopic activity in left ventricular hypertrophy. Am J Med. 1984;77:18–22.PubMedCrossRefGoogle Scholar
  86. 86.
    Bigger Jr JT, Fleiss JL, Kleiger R, et al. The relationships among ventricular arrhythmias, left ventricular dysfunction, and mortality in the 2 years after myocardial infarction. Circulation. 1984;69:250–8.PubMedCrossRefGoogle Scholar
  87. 87.
    Huikuri HV, Makikallio TH, Raatikainen MJP, Perkiomaki J, Castellanos A, Myerburg RJ. Prediction of sudden cardiac death: appraisal of the studies and methods assessing the risk of sudden arrhythmic death. Circulation. 2003;108:110–5.PubMedCrossRefGoogle Scholar
  88. 88.
    Stevenson WG, Stevenson LW, Middlekauff HR, Saxon LA. Sudden death prevention in patients with advanced ventricular dysfunction. Circula­tion. 1993;88:2953–61.PubMedCrossRefGoogle Scholar
  89. 89.
    Aronow WS, Ahn C, Mercando AD, Epstein S, Kronzon I. Prevalence and association of ventricular tachycardia and complex ventricular arrhythmias with new coronary events in older men and women with and without cardiovascular disease. J Gerontol A Biol Sci Med Sci. 2002;57:M178–80.PubMedCrossRefGoogle Scholar
  90. 90.
    Volpi A, Cavalli A, Turato R, Barlera S, Santoro E, Negri E. Incidence and short-term prognosis of late sustained ventricular tachycardia after myocardial infarction: results of the Gruppo Italiano per lo Studio Della Sopravvivenza nell’Infarto Miocardico (GISSI-3) Data Base. Am Heart J. 2001;142:87–92.PubMedCrossRefGoogle Scholar
  91. 91.
    Trusty JM, Beinborn DS, Jahangir A. Dysrhythmias and the athlete. AACN Clin Issues. 2004;15:432–48.PubMedCrossRefGoogle Scholar
  92. 92.
    Ornato JP, Peberdy MA, Tadler SC, Strobos NC. Factors associated with the occurrence of cardiac arrest during hospitalization for acute myocardial infarction in the second national registry of myocardial infarction in the US. Resuscitation. 2001;48:117–23.PubMedCrossRefGoogle Scholar
  93. 93.
    Behar S, Goldbourt U, Reicher-Reiss H, Kaplinsky E, The Principal Investigators of the SPRINT Study. Prognosis of acute myocardial infarction complicated by primary ventricular fibrillation. Am J Cardiol. 1990;66:1208–11.PubMedCrossRefGoogle Scholar
  94. 94.
    Huikuri HV, Castellanos A, Myerburg RJ. Medical progress: sudden death due to cardiac arrhythmias. N Engl J Med. 2001;345:1473–82.PubMedCrossRefGoogle Scholar
  95. 95.
    Luu M, Stevenson WG, Stevenson LW, Baron K, Walden J. Diverse mechanisms of unexpected cardiac arrest in advanced heart failure. Circulation. 1989;80:1675–80.PubMedCrossRefGoogle Scholar
  96. 96.
    Bayes de Luna A, Coumel P, Leclercq JF. Ambulatory sudden cardiac death: mechanisms of production of fatal arrhythmia on the basis of data from 157 cases. Am Heart J. 1989;117:151–9.PubMedCrossRefGoogle Scholar
  97. 97.
    Cobb LA, Fahrenbruch CE, Olsufka M, Copass MK. Changing incidence of out-of-hospital ventricular fibrillation, 1980–2000. JAMA. 2002;288:3008–13.PubMedCrossRefGoogle Scholar
  98. 98.
    Herlitz J, Andersson E, Bang A, Engdahl J, Holmberg M, Lindqvist J, et al. Experiences from treatment of out-of-hospital cardiac arrest during 17 years in Goteborg. Eur Heart J. 2000;21:1251–8.PubMedCrossRefGoogle Scholar
  99. 99.
    Schouten EG, Dekker JM, Meppelink P, Kok FJ, Vandenbroucke JP, Pool J. QT interval prolongation predicts cardiovascular mortality in an apparently healthy population. Circulation. 1991;84:1516–23.PubMedCrossRefGoogle Scholar
  100. 100.
    Steinberg JS, Berbari EJ. The signal-averaged electrocardiogram: update on clinical applications. J Cardiovasc Electrophysiol. 1996;7:972–88.PubMedCrossRefGoogle Scholar
  101. 101.
    Cook JR, Flack JE, Gregori CA, Deaton DW, Rousou JA, Engelman RM. The CABG Patch Trial. Influence of the preoperative signal-averaged electrocardiogram on left ventricular function after coronary artery bypass graft surgery in patients with left ventricular dysfunction. Am J Cardiol. 1998;82:285–9.PubMedCrossRefGoogle Scholar
  102. 102.
    Podrid PJ, Graboys TB. Exercise stress testing in the management of cardiac rhythm disorders. Med Clin North Am. 1984;68:1139–52.PubMedGoogle Scholar
  103. 103.
    Couderc JP, Zareba W, McNitt S, Maison-Blanche P, Moss AJ. Repolarization variability in the risk stratification of MADIT II patients. Europace. 2007;9:717–23.PubMedCrossRefGoogle Scholar
  104. 104.
    Bloomfield DM, Bigger JT, Steinman RC, Namerow PB, Parides MK, Curtis AB, et al. Microvolt t-wave alternans and the risk of death or sustained ventricular arrhythmias in patients with left ventricular dysfunction. J Am Coll Cardiol. 2006;47:456–63.PubMedCrossRefGoogle Scholar
  105. 105.
    Chow T, Kereiakes DJ, Bartone C, Booth T, Schloss EJ, Waller T, et al. Prognostic utility of microvolt T-wave alternans in risk stratification of patients with ischemic cardiomyopathy. J Am Coll Cardiol. 2006;47:1820–7.PubMedCrossRefGoogle Scholar
  106. 106.
    Cheitlin MD, Armstrong WF, Aurigemma GP, Beller GA, Bierman FZ, Davis JL, et al. ACC/AHA/ASE 2003 guideline update for the clinical application of echocardiography: Summary article: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASE Committee to Update the 1997 Guidelines for the Clinical Application of Echocardiography). J Am Coll Cardiol. 2003;42:954–70.PubMedCrossRefGoogle Scholar
  107. 107.
    Azaouagh A, Churzidse S, Konorza T, Erbel R. Arrhythmogenic right ventricular cardiomyopathy/dysplasia: a review and update. Clin Res cardiol. 2011;100:383–94.PubMedCrossRefGoogle Scholar
  108. 108.
    Marcus FI, McKenna WJ, Sherrill D, Basso C, Bauce B, Bluemke DA, et al. Diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia: proposed modification of the task force criteria. Circulation. 2010;121:1533–41.PubMedCrossRefGoogle Scholar
  109. 109.
    Klocke FJ, Baird MG, Lorell BH, Bateman TM, Messer JV, Berman DS, et al. ACC/AHA/ASNC guidelines for the clinical use of cardiac radionuclide imaging–executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASNC Committee to Revise the 1995 Guidelines for the Clinical Use of Cardiac Radionuclide Imaging). J Am Coll Cardiol. 2003;42:1318–33.PubMedCrossRefGoogle Scholar
  110. 110.
    Wilber DJ, Garan H, Finkelstein D, Kelly E, Newell J, McGovern B, et al. Out-of-hospital ­cardiac arrest. Use of electrophysiologic testing in the prediction of long-term outcome. N Engl J Med. 1988;318:19–24.PubMedCrossRefGoogle Scholar
  111. 111.
    Bachinsky WB, Linzer M, Weld L, Estes I, Mark NA. Usefulness of clinical characteristics in predicting the outcome of electrophysiologic studies in unexplained syncope. Am J Cardiol. 1992;69:1044–9.PubMedCrossRefGoogle Scholar
  112. 112.
    Chen LYJA, Decker WW, Smars PA, Wieling W, Hodge DO, Gersh BJ, et al. Score indices for predicting electrophysiologic outcomes in patients with unexplained syncope. J Interv Card Electrophysiol. 2005;14:99–105.PubMedCrossRefGoogle Scholar
  113. 113.
    Priori SG, Schwartz PJ, Napolitano C, Bloise R, Ronchetti E, Grillo M, et al. Risk stratification in the long-QT syndrome. N Engl J Med. 2003;348:1866–74.PubMedCrossRefGoogle Scholar
  114. 114.
    Moya A, Sutton R, Ammirati F, Blanc JJ, Brignole M, Dahm JB, et al. Guidelines for the diagnosis and management of syncope (version 2009). Eur Heart J. 2009;30:2631–71.PubMedCrossRefGoogle Scholar
  115. 115.
    Priori SG, Napolitano C, Gasparini M, Pappone C, Della Bella P, Giordano U, et al. Natural history of Brugada syndrome: insights for risk stratification and management. Circulation. 2002;105:1342–7.PubMedCrossRefGoogle Scholar
  116. 116.
    Brugada J, Brugada R, Brugada P. Determinants of sudden cardiac death in individuals with the electrocardiographic pattern of Brugada syndrome and no previous cardiac arrest. Circulation. 2003;108:3092–6.PubMedCrossRefGoogle Scholar
  117. 117.
    Nienaber CA, Hiller S, Spielmann RP, Geiger M, Kuck KH. Syncope in hypertrophic cardiomyopathy: multivariate analysis of prognostic determinants. J Am Coll Cardiol. 1990;15:948–55.PubMedCrossRefGoogle Scholar
  118. 118.
    Schmitt C, Barthel P, Ndrepepa G, Schreieck J, Plewan A, Schomig A, et al. Value of programmed ventricular stimulation for prophylactic internal cardioverter-defibrillator implantation in postinfarction patients preselected by noninvasive risk stratifiers. J Am Coll Cardiol. 2001;37:1901–7.PubMedCrossRefGoogle Scholar
  119. 119.
    Buxton AE, Lee KL, Hafley GE, Wyse DG, Fisher JD, Lehmann MH, et al. Relation of ejection fraction and inducible ventricular tachycardia to mode of death in patients with coronary artery disease: an analysis of patients enrolled in the multicenter unsustained tachycardia trial. Circula­tion. 2002;106:2466–72.PubMedCrossRefGoogle Scholar
  120. 120.
    Buxton AE, Lee KL, Fisher JD, Josephson ME, Prystowsky EU, Hafley G. A randomized study of the prevention of sudden death in patients with coronary artery disease. N Engl J Med. 1999;341:1882–90.PubMedCrossRefGoogle Scholar
  121. 121.
    Moss AJ, Hall WJ, Cannom DS, Daubert JP, Higgins SL, Klein H, et al. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. N Engl J Med. 1996;335:1933–40.PubMedCrossRefGoogle Scholar
  122. 122.
    Moss AJ, Zareba W, Hall WJ, Klein H, Wilber DJ, Cannom DS, et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med. 2002;346:877–83.PubMedCrossRefGoogle Scholar
  123. 123.
    Connolly SJ, Hallstrom AP, Cappato R, Schron EB, Kuck KH, Zipes DP, et al. Meta-analysis of the implantable cardioverter defibrillator secondary prevention trials. AVID, CASH and CIDS studies. Antiarrhythmics vs Implantable Defibrillator study. Cardiac Arrest Study Hamburg. Canadian Implantable Defibrillator Study. Eur Heart J. 2000;21:2071–8.PubMedCrossRefGoogle Scholar
  124. 124.
    Roden DM. Drug-induced prolongation of the QT interval. N Engl J Med. 2004;350:1013–22.PubMedCrossRefGoogle Scholar
  125. 125.
    Jahangir A, Terzic A, Shen WK. Antiarrhythmic drugs and future direction. In: Gussak I, Antzelevitch C, Hammill SC, Shen WK, Bjerregaard P, editors. Cardiac repolarization: bridging basic and clinical science, Contem­porary cardiology. Totowa, NJ: Humana Press; 2003. p. 387–404.CrossRefGoogle Scholar
  126. 126.
    Williams BR, Kim J. Cardiovascular drug therapy in the elderly: theoretical and practical considerations. Drugs Aging. 2003;20:445–63.PubMedCrossRefGoogle Scholar
  127. 127.
    The Cardiac Arrhythmia Suppression Trial (CAST) Investigators. Preliminary report effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction. N Engl J Med. 1989;321:406–12.CrossRefGoogle Scholar
  128. 128.
    Waldo AL, Camm AJ, deRuyter H, Friedman PL, MacNeil DJ, Pauls JF, et al. Effect of d-sotalol on mortality in patients with left ventricular dysfunction after recent and remote myocardial infarction. Lancet. 1996;348:7–12.PubMedCrossRefGoogle Scholar
  129. 129.
    Fleg JL, Aronow WS, Frishman WH. Cardiovascular drug therapy in the elderly: benefits and challenges. Nat Rev Cardiol. 2011;8:13–28.PubMedCrossRefGoogle Scholar
  130. 130.
    Hellestrand KJ, Burnett PJ, Milne JR, et al. Effect of the antiarrhythmic agent flecainide acetate on acute and chronic pacing thresholds. Pacing Clin Electrophysiol. 1983;6:892–9.PubMedCrossRefGoogle Scholar
  131. 131.
    Echt DS, Black JN, Barbey JT, Coxe DR, Cato E. Evaluation of antiarrhythmic drugs on defibrilla­tion energy requirements in dogs. Sodium channel block and action potential prolongation. Circulation. 1989;79:1106–17.PubMedCrossRefGoogle Scholar
  132. 132.
    Connolly SJ, Dorian P, Roberts RS, Gent M, Bailin S, Fain ES, et al. Comparison of [beta]-blockers, amiodarone plus [beta]-blockers, or sotalol for prevention of shocks from implantable cardioverter defibrillators – the optic study: a randomized trial. J Am Med Assoc. 2006;295:165–71.CrossRefGoogle Scholar
  133. 133.
    Pacifico A, Hohnloser SH, Williams JH, Tao B, Saksena S, Henry PD, et al. Prevention of implantable-defibrillator shocks by treatment with sotalol. N Engl J Med. 1999;340:1855–62.PubMedCrossRefGoogle Scholar
  134. 134.
    Connolly SJ. Meta-analysis of antiarrhythmic drug trials. Am J Cardiol. 1999;84:90R–3.PubMedCrossRefGoogle Scholar
  135. 135.
    Farre J, Romero J, Rubio JM, Ayala R, Castro-Dorticos J. Amiodarone and ‘primary’ prevention of sudden death: critical review of a decade of clinical trials. Am J Cardiol. 1999;83:55D–63.PubMedCrossRefGoogle Scholar
  136. 136.
    Steinberg JS, Martins J, Sadanandan S, Goldner B, Menchavez E, Domanski M, et al. Antiarrhythmic drug use in the implantable defibrillator arm of the Antiarrhythmics Versus Implantable Defibrillators (AVID) study. Am Heart J. 2001;142:520–9.PubMedCrossRefGoogle Scholar
  137. 137.
    Piccini JP, Berger JS, O’Connor CM. Amiodarone for the prevention of sudden cardiac death: a meta-analysis of randomized controlled trials. Eur Heart J. 2009;30:1245–53.PubMedCrossRefGoogle Scholar
  138. 138.
    Kuhlkamp V, Mewis C, Mermi J, Bosch RF, Seipel L. Suppression of sustained ventricular tachyarrhythmias: a comparison of d, l-sotalol with no antiarrhythmic drug treatment. J Am Coll Cardiol. 1999;33:46–52.PubMedCrossRefGoogle Scholar
  139. 139.
    Alberte C, Zipes DP. Use of nonantiarrhythmic drugs for prevention of sudden cardiac death. J Cardiovasc Electrophysiol. 2003;14:S87–95.PubMedCrossRefGoogle Scholar
  140. 140.
    Woods KL, Ketley D, Lowy A, Agusti A, Hagn C, Kala R, et al. Beta-blockers and antithrombotic treatment for secondary prevention after acute myocardial infarction. Towards an understanding of factors influencing clinical practice. Eur Heart J. 1998;19:74–9.PubMedCrossRefGoogle Scholar
  141. 141.
    Cairns JA, Connolly SJ, Roberts R, Gent M. Randomised trial of outcome after myocardial infarction in patients with frequent or repetitive ventricular premature depolarisations: CAMIAT. Lancet. 1997;349:675–82.PubMedCrossRefGoogle Scholar
  142. 142.
    Julian D, Camm A, Frangin G, Janse M, Munoz A, Schwartz P, et al. Randomised trial of effect of amiodarone on mortality in patients with left-ventricular dysfunction after recent myocardial infarction: EMIAT. Lancet. 1997;349:667–74.PubMedCrossRefGoogle Scholar
  143. 143.
    Wilber DJ, Zareba W, Hall WJ, Brown MW, Lin AC, Andrews ML, et al. Time dependence of mortality risk and defibrillator benefit after myocardial infarction. Circulation. 2004;109:1082–4.PubMedCrossRefGoogle Scholar
  144. 144.
    Hohnloser SH, Kuck KH, Dorian P, Roberts RS, Hampton JR, Hatala R, et al. Prophylactic use of an implantable cardioverter-defibrillator after acute myocardial infarction. N Engl J Med. 2004;351:2481–8.PubMedCrossRefGoogle Scholar
  145. 145.
    Connolly SJ, Gent M, Roberts RS, Dorian P, Roy D, Sheldon RS, et al. Canadian Implantable Defibrillator Study (CIDS): a randomized trial of the implantable cardioverter defibrillator against amiodarone. Circulation. 2000;101:1297–302.PubMedCrossRefGoogle Scholar
  146. 146.
    Lee KL, Hafley G, Fisher JD, Gold MR, Prystowsky EN, Talajic M, et al. Effect of implantable defibrillators on arrhythmic events and mortality in the multicenter unsustained tachycardia trial. Circulation. 2002;106:233–8. doi: 10.1161/01.Cir.0000021920.73149.C3.PubMedCrossRefGoogle Scholar
  147. 147.
    Kuck K-H, Cappato R, Siebels J, Ruppel R. Randomized comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from cardiac arrest: the Cardiac Arrest Study Hamburg (CASH). Circulation. 2000;102:748–54.PubMedCrossRefGoogle Scholar
  148. 148.
    Trappe H-J, Pfitzner P, Achtelik M, Fieguth H-G. Age dependent efficacy of implantable cardioverter-defibrillator treatment: observations in 450 patients over an 11 year period. Heart. 1997;78:364–70.PubMedGoogle Scholar
  149. 149.
    Duray G, Richter S, Manegold J, Israel CW, Grönefeld G, Hohnloser SH. Efficacy and safety of ICD therapy in a population of elderly patients treated with optimal background medication. J Interv Card Electrophysiol. 2005;V14:169–73.CrossRefGoogle Scholar
  150. 150.
    Daubert J, Sesselberg H, Huang D. Implantable cardioverter-defibrillators for primary prevention: how do the data pertain to the aged? Am J Geriatr Cardiol. 2006;15:88–92.PubMedCrossRefGoogle Scholar
  151. 151.
    Penn J, Goldenberg I, Moss AJ, McNitt S, Zareba W, Klein HU, et al. Improved outcome with preventive cardiac resynchronization therapy in the elderly: a MADIT-CRT substudy. J Cardiovasc Electrophysiol. 2011;22:892–7.PubMedCrossRefGoogle Scholar
  152. 152.
    Bardy GH, Lee KL, Mark DB, et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med. 2005;352:225–37.PubMedCrossRefGoogle Scholar
  153. 153.
    Cleland JGF, Daubert J-C, Erdmann E, Freemantle N, Gras D, Kappenberger L, et al. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med. 2005;352:1539–49.PubMedCrossRefGoogle Scholar
  154. 154.
    van Rees JB, Borleffs CJ, Thijssen J, de Bie MK, van Erven L, Cannegieter SC, et al. Prophylactic implantable cardioverter-defibrillator treatment in the elderly: therapy, adverse events, and survival gain. Europace. 2012;14:66–73.PubMedCrossRefGoogle Scholar
  155. 155.
    Jahangir ASW, Neubauer SA, Ballard DJ, Hammill SC, Hodge DO, Lohse CM, et al. Relation between mode of pacing and long-term survival in the very elderly. J Am Coll Cardiol. 1999;33:1208–16.PubMedCrossRefGoogle Scholar
  156. 156.
    Krahn AD, Connolly SJ, Roberts RS, Gent M. Diminishing proportional risk of sudden death with advancing age: implications for prevention of sudden death. Am Heart J. 2004;147:837–40.PubMedCrossRefGoogle Scholar
  157. 157.
    Geelen P, Lorga Filho A, Primo J, Wellens F, Brugada P. Experience with implantable cardioverter defibrillator therapy in elderly patients. Eur Heart J. 1997;18:1339–42.PubMedCrossRefGoogle Scholar
  158. 158.
    Panotopoulos PT, Axtell K, Anderson AJ, Sra J, Blanck Z. Efficacy of the implantable cardioverter-defibrillator in the elderly. J Am Coll Cardiol. 1997;29:556–60.PubMedCrossRefGoogle Scholar
  159. 159.
    Saksena S, Mathew P, Giorgberidze I, Krol RB, Kaushik R. Implantable defibrillator therapy for the elderly. Am J Geriatr Cardiol. 1998;7:11–3.PubMedGoogle Scholar
  160. 160.
    Wilkoff BL, Cook JR, Epstein AE, Greene L, Hallstrom AP, Hsia H, et al. Dual-chamber pacing-or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) trial. J Am Med Assoc. 2002;288:3115–23.CrossRefGoogle Scholar
  161. 161.
    Grimm W. Outcomes of elderly heart failure recipients of ICD and CRT. Int J Cardiol. 2008;125:154–60.PubMedCrossRefGoogle Scholar
  162. 162.
    Kocovic DZ. Cardiac resynchronization therapy and other new approaches for the treatment of heart failure in the elderly. Am J Geriatr Cardiol. 2006;15:108–13.PubMedCrossRefGoogle Scholar
  163. 163.
    Foley PW, Chalil S, Khadjooi K, Smith RE, Frenneaux MP, Leyva F. Long-term effects of cardiac resynchronization therapy in octogenarians: a comparative study with a younger population. Europace. 2008;10:1302–7.PubMedCrossRefGoogle Scholar
  164. 164.
    Silva RMFL, Mont L, Nava S, Rojel U, Matas M, Brugada J. Radiofrequency catheter ablation for arrhythmic storm in patients with an implantable cardioverter defibrillator. Pacing Clin Electrophysiol. 2004;27:971–5.PubMedCrossRefGoogle Scholar
  165. 165.
    Scheinman MM. Naspe survey on catheter ablation. Pacing Clin Electrophysiol. 1995;18:1474–8.PubMedCrossRefGoogle Scholar
  166. 166.
    Tchou P, Jazayeri M, Denker S, Dongas J, Caceres J, Akhtar M. Transcatheter electrical ablation of right bundle branch. A method of treating macroreentrant ventricular tachycardia attributed to bundle branch reentry. Circulation. 1988;78:246–57.PubMedCrossRefGoogle Scholar
  167. 167.
    Stevenson WG, Khan H, Sager P, Saxon LA, Middlekauff HR, Natterson PD, et al. Identification of reentry circuit sites during catheter mapping and radiofrequency ablation of ventricular tachycardia late after myocardial infarction. Circulation. 1993;88:1647–70.PubMedCrossRefGoogle Scholar
  168. 168.
    Gurevitz OTGM, Asirvatham S, Kester TA, Grice SK, Munger TM, Rea RF, et al. Use of advanced mapping systems to guide ablation in complex cases: experience with noncontact mapping and electroanatomic mapping systems. Pacing Clin Electrophysiol. 2005;28:316–23.PubMedCrossRefGoogle Scholar
  169. 169.
    Joshi S, Wilber DJ. Ablation of idiopathic right ventricular outflow tract tachycardia: current perspectives. J Cardiovasc Electrophysiol. 2005;16:S52–8. doi: 10.1111/j.1540-8167.2005.50163.X.PubMedCrossRefGoogle Scholar
  170. 170.
    Pedrinazzi C, Durin O, Agricola P, Romagnoli P, Inama G. Efficacy and safety of radiofrequency catheter ablation in the elderly. J Interv Card Electrophysiol. 2007;19:179–85.PubMedCrossRefGoogle Scholar
  171. 171.
    Inada K, Roberts-Thomson KC, Seiler J, Steven D, Tedrow UB, Koplan BA, et al. Mortality and safety of catheter ablation for antiarrhythmic drug-refractory ventricular tachycardia in elderly patients with coronary artery disease. Heart Rhythm. 2010;7:740–4.PubMedCrossRefGoogle Scholar
  172. 172.
    Kelly P, Ruskin JN, Vlahakes GJ, Buckley Jr MJ, Freeman CS, Garan H. Surgical coronary revascularization in survivors of prehospital cardiac arrest: its effect on inducible ventricular arrhythmias and long-term survival. J Am Coll Cardiol. 1990;15:267–73.PubMedCrossRefGoogle Scholar
  173. 173.
    Brugada J, Aguinaga L, Mont L, Betriu A, Mulet J, Sanz G. Coronary artery revascularization in patients with sustained ventricular arrhythmias in the chronic phase of a myocardial infarction: effects on the electrophysiologic substrate and outcome. J Am Coll Cardiol. 2001;37:529–33.PubMedCrossRefGoogle Scholar
  174. 174.
    Natale A, Sra J, Axtell K, Maglio C, Dhala A, Blanck Z, et al. Ventricular fibrillation and polymorphic ventricular tachycardia with critical coronary artery stenosis: does bypass surgery suffice? J Card Electrophysiol. 1994;5:988–94.CrossRefGoogle Scholar

Copyright information

© Springer-Verlag London 2013

Authors and Affiliations

  1. 1.Center for Integrative Research on Cardiovascular Aging (CIRCA)Aurora University of Wisconsin Medical Group, Aurora Health CareMilwaukeeUSA
  2. 2.Division of Cardiovascular Diseases, Department of MedicineMayo Clinic College of Medicine, Mayo Clinic ArizonaPhoenixUSA
  3. 3.Center for Integrative Research on Cardiovascular Aging (CIRCA)Aurora University of Wisconsin Medical Group, Aurora Health CareMilwaukeeUSA

Personalised recommendations